In Zhytomyr, Ukraine, Doctors Without Borders/Médecins Sans Frontières (MSF) works with the Regional TB Dispensary to treat patients who have drug-resistant forms of tuberculosis (DR-TB). Most patients in this program can be treated with an all-oral course of medication—including the new medications delamanid and bedaquiline—instead of the painful injections that were previously used and caused serious side-effects. After patients are treated with a short course of DR-TB medication, they are discharged with additional treatments they can take at home, allowing them to get back to their lives, families, and careers sooner. But many patients still struggle to keep taking their medication for the full 9 to 12 months.
“When I got TB, I lost the will to live. My grandparents had told me that TB was a slow death,” said DR-TB survivor Natalia Tsopa.* “During the treatment, I felt ill and tired. I lost a lot of weight, too. I was irritable, I was depressed, and my psychologists, Vova and Lesya, counseled me. I used to speak with the psychologists about my family, my aspirations, and how to recover.”
Counseling and social support can help patients to continue their treatment even when it is difficult. “The goal of eliminating tuberculosis remains unreached, driven by multiple factors, including lack of patient adherence to treatment,” said MSF psychiatrist Iryna Yakymuk. “Mental health problems are one of the main reasons for this. Psychiatric and drug addiction diseases, as well as psychological problems such as social isolation, stigmatization, and self-stigmatization, all negatively affect patients' adherence to treatment.”
In order to enhance patient autonomy, MSF’s program offers a combination of directly observed (DOT), video-observed (VOT), and self-administered (SAT) therapies, tailored to the needs and capacities of the patients. In DOT and VOT therapies, a trained health worker observes patients as they take their prescribed drugs, either in person or through video-enabled smartphones.
Even with these systems in place, patients face other practical challenges. In MSF’s program, patient support teams of nurses, social workers, and psychologists work with DR-TB patients to understand and resolve potential barriers to completing treatment, from unpaid pensions to lack of gas or heating in their homes. DR-TB can be cured, but only if patients are able to complete their treatment. Coordinated patient support—including doctors, nurses, TB specialists, psychologists, and social workers—must be a central part of their treatment.
The following testimonies are from patients who were treated for DR-TB through MSF’s partnership with the Regional TB Dispensary in Zhytomyr. They reflect on their experiences with DR-TB and the MSF patient support teams that work with them to understand and resolve potential barriers to continuing treatment.